VeriSeq™ NIPT Solution v2: Expect the extraordinary in prenatal screening
VeriSeq NIPT Solution v2. A workflow that works with you.
Ease: A simple, easy-to-use, automated system that seamlessly integrates into your lab’s current workflow and flexes with your lab’s growing needs.
Accuracy: An in-lab IVD NIPT screening assay solution that delivers high accuracy with greater than or equal to 99.9% sensitivity and specificity. Results you and your clinicians can trust.
Speed: Results in approximately 26 hours with only 2 hours of hands-on time means clinicians and their expecting families get answers faster.
For In Vitro Diagnostics Use. Not available in all regions and countries.
Subscribe to the Illumina video channel http://www.youtube.com/subscription_c...
A global genomics leader, Illumina provides comprehensive next-generation sequencing solutions to the research, clinical, and applied markets. Illumina technology is responsible for generating more than 90% of the world’s sequencing data.* Through collaborative innovation, Illumina is fueling groundbreaking advancements in oncology, reproductive health, genetic disease, microbiology, agriculture, forensic science, and beyond.
*Data calculations on file. Illumina, Inc., 2015.
View customer spotlight videos
• Illumina Customer Testimonials
View Illumina webinars
• Webinars
View Illumina product videos
• Playlist
View Illumina support videos
• Illumina Support
Facebook: / illuminainc
LinkedIn: / illu. .
Instagram: / illuminainc
Twitter: / illumina
